Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
D444A
the mutant shows increased catalytic efficiency compared to the wild type enzyme
D444R
the mutant shows increased catalytic efficiency compared to the wild type enzyme
D444Y
the mutant shows decreased catalytic efficiency compared to the wild type enzyme
D546A
-
the enzyme shows wild type activity but is not inhibited by L-leucine
D563A
-
the enzyme is more sensitive to L-leucine inhibition compared to the wild type enzyme
D564A
-
the enzyme is less sensitive to L-leucine inhibition compared to the wild type enzyme
D81A
-
the mutant shows strongly decreased activity compared to the wild type enzyme
D81E
-
the mutant shows strongly decreased activity compared to the wild type enzyme
D81E/N321I
-
the mutant shows strongly decreased activity compared to the wild type enzyme
E218A
mutant, substitution at phylogenetically conserved active site residue near the interface of the catalytic and linker domains
H167A
the mutant shows reduced activity compared to the wild type enzyme
H379A
mutant, substitution at phylogenetically conserved active site residue near the interface of the catalytic and linker domains
H540A
-
the enzyme is less sensitive to L-leucine inhibition compared to the wild type enzyme
L143A
the mutant shows reduced activity compared to the wild type enzyme
L143N
the mutant shows reduced activity compared to the wild type enzyme
M559A
-
the enzyme is less sensitive to L-leucine inhibition compared to the wild type enzyme
N250A
the mutant shows reduced activity and is able to use (3RS)-3-methyl-2-oxovalerate and 4-methyl-2-oxovalerate as substrates compared to the wild type enzyme
N321A
-
the mutant shows strongly decreased activity compared to the wild type enzyme
N321I
-
the mutant shows strongly decreased activity compared to the wild type enzyme
Q566A
-
the enzyme is more sensitive to L-leucine inhibition compared to the wild type enzyme
Q84A
-
the mutant exhibits kcat values similar to that of the L-leucine inhibited wild type enzyme
R97A
the mutant shows increased catalytic efficiency compared to the wild type enzyme
S216G
the mutant shows reduced activity and is able to use (3RS)-3-methyl-2-oxovalerate and 4-methyl-2-oxovalerate as substrates compared to the wild type enzyme
S560W
-
the mutation does not affect the activity of the enzyme, but the enzyme is less sensitive to L-leucine inhibition compared to the wild type enzyme
Y169A
the mutant shows reduced activity compared to the wild type enzyme
Y169F
mutant, substitution at phylogenetically conserved active site residue near the interface of the catalytic and linker domains
Y169H
the mutant shows reduced activity compared to the wild type enzyme
E218A
-
mutant, substitution at phylogenetically conserved active site residue near the interface of the catalytic and linker domains
-
H379A
-
mutant, substitution at phylogenetically conserved active site residue near the interface of the catalytic and linker domains
-
Y169F
-
mutant, substitution at phylogenetically conserved active site residue near the interface of the catalytic and linker domains
-
E365Term
mutant, truncated form of NmeIPMS, loss of the regulatory domain results in a loss of the ability to catalyse the adol reaction, although the enzyme is still able to slowly hydrolyse AcCoA
D578Y
-
release of leucine feedback inhibition and hyperproduction of isoamyl alcohol in mutant cells. Mutant shows resistance to 5,5,5-trifluoro-DL-leucine
D563N
-
the enzyme is more sensitive to L-leucine inhibition compared to the wild type enzyme
D563N
-
the enzyme shows wild type activity but is not inhibited by L-leucine
Y410F
mutant, insensitive to feedback inhibition
Y410F
-
mutant, insensitive to L-leucine inhibition
Y410F
mutant, insensitive to L-leucine inhibition
Y410F
-
the mutant is insensitive to L-leucine inhibition despite retaining significant binding affinity for the molecule
Y410F
-
the mutant exhibits kcat values similar to that of the L-leucine inhibited wild type enzyme
Y410F
-
mutant, insensitive to L-leucine inhibition
-
Y410F
-
mutant, insensitive to feedback inhibition
-
G516S
-
in mutant strain T25 with L-leucine accumulation, a hetero allelic mutation in the LEU4 gene encoding the Gly516Ser variant alpha-isopropylmalate synthase is found. alpha-Isopropylmalate synthase activity of the Gly516Ser variant is less sensitive to feedback inhibition by L-leucine, leading to intracellular L-leucine accumulation. In a laboratory-scale test, awamori (a distilled alcoholic beverage made from steamed rice,) brewed with strain T25 shows higher concentrations of isoamyl alcohol and isoamyl acetate than that brewed with strain HC02-5-2. Such a combinatorial approach to yeast isolation, with whole genome analysis and metabolism-focused breeding, has the potentials to vary the quality of alcoholic beverages
G516S
-
in mutant strain T25 with L-leucine accumulation, a hetero allelic mutation in the LEU4 gene encoding the Gly516Ser variant alpha-isopropylmalate synthase is found. alpha-Isopropylmalate synthase activity of the Gly516Ser variant is less sensitive to feedback inhibition by L-leucine, leading to intracellular L-leucine accumulation. In a laboratory-scale test, awamori (a distilled alcoholic beverage made from steamed rice,) brewed with strain T25 shows higher concentrations of isoamyl alcohol and isoamyl acetate than that brewed with strain HC02-5-2. Such a combinatorial approach to yeast isolation, with whole genome analysis and metabolism-focused breeding, has the potentials to vary the quality of alcoholic beverages
-
additional information
-
knockout-mutant of isoform IPMS1 shows an increase in valine content, but no change in leucine content. Insertion mutation for isoform IPMS2 do not show any changes in soluble amino acid content.
additional information
knockout-mutant of isoform IPMS1 shows an increase in valine content, but no change in leucine content. Insertion mutation for isoform IPMS2 do not show any changes in soluble amino acid content.
additional information
knockout-mutant of isoform IPMS1 shows an increase in valine content, but no change in leucine content. Insertion mutation for isoform IPMS2 do not show any changes in soluble amino acid content.
additional information
mutations in the Arabidopsis ROL17/isopropylmalate synthase 1 locus alter amino acid content, modify the TOR network, and suppress the root hair cell development mutant lrx1
additional information
-
mutations in the Arabidopsis ROL17/isopropylmalate synthase 1 locus alter amino acid content, modify the TOR network, and suppress the root hair cell development mutant lrx1
additional information
overexpression of enzyme in Arabidopsis thaliana results in plants with an aberrant phenotype. Plants have both perturbed amino acid metabolism and enhanced levels of glucosinolates. Overexpression causes upregulation of the genes for methionine-derived glucosinolate biosynthesis, and downregulation of genes involved in leucine catabolism
additional information
the LeuA425 protein lacks the C-terminal allosteric regulatory domain of the wild type enzyme and is inactive
additional information
-
the LeuA425 protein lacks the C-terminal allosteric regulatory domain of the wild type enzyme and is inactive
additional information
-
the LeuA425 protein lacks the C-terminal allosteric regulatory domain of the wild type enzyme and is inactive
-
additional information
the E365Term protein lacks the C-terminal allosteric regulatory domain of the wild type enzyme and is inactive
additional information
-
the E365Term protein lacks the C-terminal allosteric regulatory domain of the wild type enzyme and is inactive